Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB1 | P05556 | 6/20 | 0.45 |
| ▸ | ITGA4 | P13612 | 6/20 | 0.45 |
| ▸ | OXTR | P30559 | 2/20 | 0.40 |
| ▸ | AVPR1A | P37288 | 2/20 | 0.40 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.37 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.33 |
| ▸ | ITGB7 | P26010 | 2/20 | 0.33 |
| ▸ | MME | P08473 | 1/20 | 0.33 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.32 |
| ▸ | CTSL | P07711 | 2/20 | 0.32 |
| ▸ | CTSB | P07858 | 2/20 | 0.32 |
| ▸ | CTSS | P25774 | 2/20 | 0.32 |
| ▸ | CTSK | P43235 | 1/20 | 0.32 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8363926 | 0.85 | FFAR1 (0.44) | ITGB1ITGA4OXTRAVPR1AFFAR1 | |
| SCHEMBL3473579 | 0.82 | ITGB1 (0.41) | ITGB1ITGA4OXTRAVPR1AFFAR1 | |
| SCHEMBL3473583 | 0.82 | ITGB1 (0.41) | ITGB1ITGA4OXTRAVPR1AFFAR1 | |
| SCHEMBL3473577 | 0.79 | FFAR1 (0.46) | ITGB1ITGA4OXTRAVPR1AFFAR1 | |
| SCHEMBL3473572 | 0.79 | FFAR1 (0.46) | ITGB1ITGA4OXTRAVPR1AFFAR1 | |
| SCHEMBL3664 | 0.77 | FFAR1 (0.45) | ITGB1ITGA4OXTRAVPR1AFFAR1 | |
| SCHEMBL2651 | 0.76 | ALDH1A1 (0.52) | ITGB1ITGA4OXTRAVPR1AFFAR1 | |
| SCHEMBL29378073 | 0.76 | AGTR1 (0.54) | FFAR1AKR1B1AGTR1 | |
| SCHEMBL1809623 | 0.76 | AGTR1 (0.54) | FFAR1AKR1B1AGTR1 | |
| SCHEMBL2140 | 0.76 | AGTR1 (0.54) | FFAR1AKR1B1AGTR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2003094915-A1 | USE OF VALSARTAN OT ITS METABOLITE TO INHIBIT PLATELET AGGREGATION | NOVARTIS AG (CH) | 2003-11-20 | — | — | WO | disclosed |